Guided Therapeutics (GTHP) Operating Expenses (2010 - 2026)

Guided Therapeutics has disclosed Operating Expenses across 17 years of filings, most recently posting $478000.0 for Q2 2026.

• In Q2 2026, Operating Expenses fell 43.23% year-over-year to $478000.0; the TTM figure through Jun 2026 stood at $2.5 million (up 5.07% YoY), while the FY2025 annual figure was $2.9 million, up 39.48% from the prior year.
• Operating Expenses came in at $478000.0 for Q2 2026 at Guided Therapeutics, up from $302000.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.5 million in Q2 2023 to a low of $302000.0 in Q1 2026.
• Average Operating Expenses over 5 years is $699500.0, with a median of $590000.0 recorded in 2023.
• Year-over-year, Operating Expenses jumped 164.44% in 2022 and tumbled 57.59% in 2024.
• Over 5 years, Operating Expenses stood at $869000.0 in 2022, then tumbled by 42.35% to $501000.0 in 2023, then climbed by 6.19% to $532000.0 in 2024, then jumped by 119.55% to $1.2 million in 2025, then tumbled by 59.08% to $478000.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $478000.0 in Q2 2026, $302000.0 in Q1 2026, and $1.2 million in Q4 2025.